 Peanut allergy can be life-threatening. Current diagnostic techniques for peanut allergy have high sensitivity, but not high specificity. This clinical trial will test the validity of a novel blood biomarker compared with current testing as a diagnostic predictor of anaphylaxis to peanut. 